1073065-21-0

Basic information

• Product Name: 7-(3-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1-(pyridin-3-ylmethyl)-1H-indole-2-carboxylic acid
• Synonyms: 7-(3-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1-(pyridin-3-ylmethyl)-1H-indole-2-carboxylic acid
• CAS NO: 1073065-21-0
• Molecular Weight: 762.908
• Mol File: 1073065-21-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 7-(3-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1-(pyridin-3-ylmethyl)-1H-indole-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(3-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1-(pyridin-3-ylmethyl)-1H-indole-2-carboxylic acid(1073065-21-0)
• EPA Substance Registry System: 7-(3-((4-(4-acetylpiperazin-1-yl)phenoxy)methyl)-1,5-dimethyl-1H-pyrazol-4-yl)-3-(3-(naphthalen-1-yloxy)propyl)-1-(pyridin-3-ylmethyl)-1H-indole-2-carboxylic acid(1073065-21-0)

Safety Data

• Hazardous Substances Data: 1073065-21-0(Hazardous Substances Data)

Upstream product

• 1073067-98-7 ethyl 7-bromo-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylate 
• 1073067-97-6 ethyl 7-bromo-3-(3-hydroxypropyl)-1H-indole-2-carboxylate 
• 1073067-96-5 3-(7-bromo-2-(ethoxycarbonyl)-1H-indol-3-yl)propanoic acid 
• 1073493-75-0 ethyl 7-bromo-3-(3-ethoxy-3-oxopropyl)-1H-indole-2-carboxylate 
• 615-36-1 2-bromoaniline 
• 615-79-2 ethyl 2,4-diketopentanoate 
• 611-10-9 2-ethoxycarbonyl-1-cyclopentanone 
• 153912-60-8 (1,5-dimethyl-1H-pyrazol-3-yl)methanol 
• 5744-51-4 ethyl 1,5-dimethyl-1H-pyrazole-3-carboxylate 
• 4027-57-0 ethyl 5-methyl-1H-pyrazole-3-carboxylate 
• 1073493-89-6 ethyl 7-bromo-1-(2-morpholinoethyl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylate 
• 1073493-88-5 ethyl 7-bromo-1-(2-morpholino-2-oxoethyl)-3-(3-(naphthalen-1-yloxy)propyl)-1H-indole-2-carboxylate 

Relevant articles and documents

Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity

Myeloid cell leukemia 1 (MCL-1) is a BCL-2 family protein that has been implicated in the progression and survival of multiple tumor types. Herein we report a series of MCL-1 inhibitors that emanated from a high throughput screening (HTS) hit and progressed via iterative cycles of structure-guided design. Advanced compounds from this series exhibited subnanomolar affinity for MCL-1 and excellent selectivity over other BCL-2 family proteins as well as multiple kinases and GPCRs. In a MCL-1 dependent human tumor cell line, administration of compound 30b rapidly induced caspase activation with associated loss in cell viability. The small molecules described herein thus comprise effective tools for studying MCL-1 biology.